A
Ascendis Pharma
Long-acting prodrug therapies for rare endocrine diseases
At a glance
- Founded
- 2007
- Headquarters
- Gentofte Municipality, Denmark
- Listing
- IPO 2015
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Ascendis Pharma.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Sofinnova Partners- GHGilde Healthcare
Series B and later6 investors entered at this stage
- RCRock Springs Capital
OrbiMed
RA Capital Management
Vivo Capital- SISofinnova Investments
Venrock
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
112 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Ascendis Pharma was the backer or acquirer, 2018–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Ascendis Pharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Ascendis Pharma deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Ascendis Pharma's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ascendis Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ascendis Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.